Rankings
▼
Calendar
TEVA Q3 2016 Earnings — Teva Pharmaceutical Industries Limited Revenue & Financial Results | Market Cap Arena
TEVA
Teva Pharmaceutical Industries Limited
$35B
Q3 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$5.6B
Gross Profit
$2.8B
50.4% margin
Operating Income
$765M
13.8% margin
Net Income
$348M
6.3% margin
EPS (Diluted)
$0.35
QoQ Revenue Growth
+10.4%
Cash Flow
Operating Cash Flow
$1.5B
Free Cash Flow
$1.2B
Stock-Based Comp.
$31M
Balance Sheet
Total Assets
$98.7B
Total Liabilities
$61.7B
Stockholders' Equity
$35.1B
Cash & Equivalents
$1.6B
← FY 2016
All Quarters
Q4 2016 →
